Clinical trial
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
NCT02505919 · PROCEPT BioRobotics, Industry · Completed
Key facts
| NCT number | NCT02505919 |
|---|---|
| Title | Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER) |
| Official title | A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS |
| Acronym | WATER |
| Lead sponsor | PROCEPT BioRobotics, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Benign Prostatic Hyperplasia (BPH) |
| Intervention type | Device, Procedure |
| Interventions | AQUABEAM System, Transurethral Resection of the Prostate (TURP) |
| Enrollment | 184 |
| Start date | Oct 30, 2015 |
| Primary completion | Jul 14, 2017 |
| Completion | Dec 16, 2021 |
| First posted | Jul 22, 2015 |
| Last update posted | Jul 3, 2023 |
| Countries | Australia, New Zealand, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: